Oncotarget is an open-access medical journal which is peer-reviewed and covers all fields of oncology as well as issues related to microbiology, immunology, aging, and chromosomes. The Journal has over hundreds of board members and editors who are the specialist in the fields that the journal covers. It was founded in 2010, and it has published six volumes and over 300 issues since then. It is now on the 8th volume and issues 47 to 50 were processed by National Library of medicine. The journal is among the first to submit an entire issue of publication to PubMed. It is published in Impact Journals with weekly publications. Its editors-in-chief are Mikhail Blagosklonny and Andrei Gudkov who work at Rosewell park cancer institute. The journal works with high profile scientific directories in order to make scientific results and research available to all researchers working in the medical field, medical students and the general public. The journal has been publishing two issues weekly; on Tuesdays and Fridays in order to provide information and news immediately it comes out as well as cover all aspects of the medical field widely. In 2013, four of the board members were awarded the Breakthrough Prize in appreciation of the excellent work the journal is doing worldwide.

The Journal nurtures the application of basic and clinical science to fight diseases. It has largely contributed to the removal of borders between researchers and specialists, therefore, giving them a chance to learn from each other and improve the medical research field. This has greatly contributed to the progress of research institutes as well as individuals. The organization’s main objective is to create a world without diseases especially cancer. Therefore, it accepts research papers from all over the world.

According to MEDLINE, the journal plays a critical role in the medical field by publishing basic medical research papers while following ethics as well as good editorial practices. This is because it publishes each paper under the recommendations of the Committee on Publication Ethics and gives each paper a Direct Object Identifier (DOI). The journal accepts papers from researchers, edits them then publishes the papers and releases them under PubMed in their permanent form.

Facebook: https://www.facebook.com/Oncotarget/

Comments closed.